Publications
Detailed Information
Serial Retinal Nerve Fiber Layer Changes in Patients With Toxic Optic Neuropathy Associated With Antituberculosis Pharmacotherapy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Yong-Kyu | - |
dc.contributor.author | Hwang, Jeong-Min | - |
dc.date.accessioned | 2012-06-29T05:14:42Z | - |
dc.date.available | 2012-06-29T05:14:42Z | - |
dc.date.issued | 2009-12 | - |
dc.identifier.citation | JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS; Vol.25 6; 531-535 | - |
dc.identifier.issn | 1080-7683 | - |
dc.identifier.uri | https://hdl.handle.net/10371/77932 | - |
dc.description.abstract | Purpose: To analyze serial changes in retinal nerve fiber layer (RNFL) thickness after development of visual loss in patients with toxic optic neuropathy (TON) associated with antituberculosis pharmacotherapy, as well as to determine if RNFL changes correlate with clinical findings. Methods: Five patients with TON underwent serial optical coherence tomography (OCT) and ophthalmologic examination, which consisted of visual acuity, color vision, pupillary light reflexes, visual fields, and funduscopy. Results: Four of the five patients showed normal RNFL thickness on initial OCT. RNFL thickness remained within normal range throughout the follow-up period (range 5.5-50.5 months, average 22.0 +/- 24.8 months after initial visual symptoms) in 3 patients and gradually decreased in 2 patients (4 and 26.5 months after initial visual symptoms), especially in the temporal segment. All patients exhibited improved visual acuity and visual fields. Four patients showed improved color vision. Conclusions: RNFL changes may not be obvious at initial presentation, but became manifest in 2 of the 5 patients over time. OCT may not be useful in identifying the RNFL defect in the early stage, but may be helpful for the follow up of the patients with TON. | - |
dc.language.iso | en | - |
dc.publisher | MARY ANN LIEBERT INC | - |
dc.title | Serial Retinal Nerve Fiber Layer Changes in Patients With Toxic Optic Neuropathy Associated With Antituberculosis Pharmacotherapy | - |
dc.type | Article | - |
dc.contributor.AlternativeAuthor | 김용규 | - |
dc.contributor.AlternativeAuthor | 황정민 | - |
dc.identifier.doi | 10.1089/jop.2009.0064 | - |
dc.citation.journaltitle | JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS | - |
dc.description.citedreference | Kim U, 2009, EUR J OPHTHALMOL, V19, P466 | - |
dc.description.citedreference | Sato S, 2008, ACTA OPHTHALMOL, V86, P609, DOI 10.1111/j.1600-0420.2007.01108.x | - |
dc.description.citedreference | Falsini B, 2008, GRAEF ARCH CLIN EXP, V246, P1153, DOI 10.1007/s00417-008-0808-5 | - |
dc.description.citedreference | Miglior S, 2007, AM J OPHTHALMOL, V144, P733, DOI 10.1016/j.ajo.2007.06.035 | - |
dc.description.citedreference | Chai SJ, 2007, BRIT J OPHTHALMOL, V91, P895, DOI 10.1136/bjo.2006.113118 | - |
dc.description.citedreference | Zoumalan CI, 2007, BRIT J OPHTHALMOL, V91, P839, DOI 10.1136/bjo.2006.107326 | - |
dc.description.citedreference | Ajtony C, 2007, INVEST OPHTH VIS SCI, V48, P258, DOI 10.1167/iovs.06-0410 | - |
dc.description.citedreference | VISTAMEHR S, 2007, SEMIN OPHTHALMOL, V22, P141 | - |
dc.description.citedreference | CHAN RY, 2006, HONG KONG MED J, V12, P56 | - |
dc.description.citedreference | Hadjikoutis S, 2005, EUR J NEUROL, V12, P499 | - |
dc.description.citedreference | Zoumalan CI, 2005, GRAEF ARCH CLIN EXP, V243, P410, DOI 10.1007/s00417-004-1053-1 | - |
dc.description.citedreference | Sivakumaran P, 1998, NEW ZEAL MED J, V111, P428 | - |
dc.description.tc | 2 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.